These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21356295)

  • 21. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
    Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
    Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G; Park TG
    J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A; Burgess DJ
    Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
    Han Y; Tian H; He P; Chen X; Jing X
    Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine.
    Regnier-Delplace C; Thillaye du Boullay O; Siepmann F; Martin-Vaca B; Degrave N; Demonchaux P; Jentzer O; Bourissou D; Siepmann J
    Int J Pharm; 2013 Feb; 443(1-2):68-79. PubMed ID: 23313920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of additives on the release of a model protein from PLGA microspheres.
    Kang F; Singh J
    AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
    Huo D; Deng S; Li L; Ji J
    Int J Pharm; 2005 Jan; 289(1-2):63-7. PubMed ID: 15652199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
    Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
    Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.